MCL1 and lymphoma: In line with this, the overexpression of Mcl-1 dramatically accelerated the onset of lymphoma developed in the Eμ-Myc tumor model and were resistant to in vivo treatment using cyclophosphamide (Adams et al., 1985; Campbell et al., 2010).